Author Affiliations: Department of Neurology, Washington University School of Medicine, St Louis, Missouri (Dr Gutmann); Department of Neurology, Children's National Medical Center, Washington, DC (Dr Avery); Department of Neurology, Guy's and St Thomas' Hospitals, London, England (Dr Ferner); and Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois (Dr Listernick).
The recent letter by Parsa1 regarding visual function and the clinical behavior of optic pathway glioma (OPG) raises several critically significant points worthy of clarification and further discussion. The importance of this debate should not be understated as it is crucial to our approach to the treatment of young children at risk for irreversible vision loss. For clarity, we will address each of Parsa's points systematically.
Gutmann DH, Avery R, Ferner RE, Listernick R. Visual Function and Optic Pathway Glioma: A Critical Response. JAMA Ophthalmol. 2013;131(1):120-124. doi:10.1001/jamaophthalmol.2013.571